February 25, 2026
The Manufacturing Bottleneck That Defines Cellular Therapy Economics The cellular therapy revolution faces a fundamental economic challenge: autologous manufacturing costs between $78,000 and $93,000 per patient before hospital administration begins, with facility costs alone comprising 51-56% of total production expenses. This isn't scalable manufacturing in the traditional pharmaceutical sense. It's […]
